We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Standex International Corporation (SXI - Free Report) ) has long been viewed as a viable industrial products manufacturer with exposure to electronics, engineering technologies, and specialty manufacturing markets. However, despite pockets of operational strength, Standex stock is starting to flash warning signs that investors should not ignore.
SXI currently carries a Zacks Rank #5 (Strong Sell), reflecting a sharply negative trend in earnings estimate revisions — one of the most powerful indicators of future stock underperformance.
While the broader market has remained resilient, analysts have become increasingly pessimistic about Standex’s earnings outlook over the last several months. That deterioration in sentiment is a key reason investors may want to avoid SXI right now, and it may be a good time to lock in any profits over the last few years.
Image Source: Zacks Investment Research
Recent Earnings Results Have Hurt Sentiment
Although Standex has occasionally delivered earnings beats, its most recent fiscal third quarter results were subpar, causing SXI to fall 8% in the last month.
The company posted Q3 earnings of $2.21 per share, narrowly missing the Zacks Consensus Estimate of $2.22. Furthermore, Q3 revenue of $224.6 million also came in slightly below expectations.
This comes as management continues to face a mixed demand environment across several end markets, while macroeconomic uncertainty and slowing industrial activity remain headwinds.
Image Source: Zacks Investment Research
Declining EPS Revisions
One of the biggest concerns surrounding Standex is the steady decline in consensus EPS estimates across nearly every important reporting period.
Based on the latest consensus estimate trend data, analysts have reduced earnings expectations significantly over the last 60 days:
Current quarter (Q4) EPS estimates have fallen from $2.52 to $2.30
Next quarter estimates have dropped from $2.13 to $2.02
Current fiscal-year 2026 EPS projections have declined from $8.83 to $8.59
Next year (FY27) EPS estimates have slid from $10.30 to $9.67
That persistent downward revision cycle is particularly concerning because estimate cuts often precede stock underperformance.
Empirical research behind the Zacks Rank system shows that stocks experiencing negative estimate revisions tend to lag the broader market. In SXI’s case, the magnitude of the cuts has been meaningful and broad-based.
Image Source: Zacks Investment Research
SXI’s Valuation Leaves Little Room for Error
Another issue for investors is valuation. Despite weakening earnings momentum, SXI still trades at a relatively elevated 30X forward earnings multiple compared to its Zacks Manufacturing-General Industrial Industry average of 22X, which includes a number of more favorably rated stocks such as Generac Holdings (GNRC - Free Report) ) and Tennant (TNC - Free Report) ), just to name a few.
That premium becomes difficult to justify when earnings expectations are falling instead of rising like many of its aforementioned peers.
Image Source: Zacks Investment Research
Bottom Line
Because the industrial products sector tends to be cyclical, these stocks need positive momentum, and SXI doesn’t have it at the moment.
The market often rewards industrial products stocks that are showcasing accelerating demand trends, expanding margins, and rising earnings forecasts. Unfortunately, Standex is currently moving in the opposite direction in those regards.
Until estimate revisions stabilize and analysts regain confidence in Standex’s growth outlook, investors may be better off focusing on stocks with improving earnings momentum instead.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Bear of the Day: Standex International (SXI)
Standex International Corporation (SXI - Free Report) ) has long been viewed as a viable industrial products manufacturer with exposure to electronics, engineering technologies, and specialty manufacturing markets. However, despite pockets of operational strength, Standex stock is starting to flash warning signs that investors should not ignore.
SXI currently carries a Zacks Rank #5 (Strong Sell), reflecting a sharply negative trend in earnings estimate revisions — one of the most powerful indicators of future stock underperformance.
While the broader market has remained resilient, analysts have become increasingly pessimistic about Standex’s earnings outlook over the last several months. That deterioration in sentiment is a key reason investors may want to avoid SXI right now, and it may be a good time to lock in any profits over the last few years.
Image Source: Zacks Investment Research
Recent Earnings Results Have Hurt Sentiment
Although Standex has occasionally delivered earnings beats, its most recent fiscal third quarter results were subpar, causing SXI to fall 8% in the last month.
The company posted Q3 earnings of $2.21 per share, narrowly missing the Zacks Consensus Estimate of $2.22. Furthermore, Q3 revenue of $224.6 million also came in slightly below expectations.
This comes as management continues to face a mixed demand environment across several end markets, while macroeconomic uncertainty and slowing industrial activity remain headwinds.
Image Source: Zacks Investment Research
Declining EPS Revisions
One of the biggest concerns surrounding Standex is the steady decline in consensus EPS estimates across nearly every important reporting period.
Based on the latest consensus estimate trend data, analysts have reduced earnings expectations significantly over the last 60 days:
That persistent downward revision cycle is particularly concerning because estimate cuts often precede stock underperformance.
Empirical research behind the Zacks Rank system shows that stocks experiencing negative estimate revisions tend to lag the broader market. In SXI’s case, the magnitude of the cuts has been meaningful and broad-based.
Image Source: Zacks Investment Research
SXI’s Valuation Leaves Little Room for Error
Another issue for investors is valuation. Despite weakening earnings momentum, SXI still trades at a relatively elevated 30X forward earnings multiple compared to its Zacks Manufacturing-General Industrial Industry average of 22X, which includes a number of more favorably rated stocks such as Generac Holdings (GNRC - Free Report) ) and Tennant (TNC - Free Report) ), just to name a few.
That premium becomes difficult to justify when earnings expectations are falling instead of rising like many of its aforementioned peers.
Image Source: Zacks Investment Research
Bottom Line
Because the industrial products sector tends to be cyclical, these stocks need positive momentum, and SXI doesn’t have it at the moment.
The market often rewards industrial products stocks that are showcasing accelerating demand trends, expanding margins, and rising earnings forecasts. Unfortunately, Standex is currently moving in the opposite direction in those regards.
Until estimate revisions stabilize and analysts regain confidence in Standex’s growth outlook, investors may be better off focusing on stocks with improving earnings momentum instead.